Charles River Laboratories International, Inc. Overview
Company Headquarters: Massachusetts, US
Founded: 1947
Workforce: ~ 18,600
Company Working: Charles River Laboratories provides clinical testing and drug development services for vaccines, biosimilars, and medicines to treat several chronic diseases such as cardiovascular, skeletal, endocrine, central nervous system, cancer, and other diseases. It offers its services all around the world. The company operates through three segments, namely, Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (MS). The RMS segment sells research model strains and purpose-bred rats and mice for use by researchers. It also offers research models, genetically altered models & services, insourcing solutions, and research animal diagnostic services to help clients support the use of research models in research and screening of non-clinical drug candidates. The DSA segment provides early and in vivo discovery services, including toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, pharmacokinetics services, and safety assessment services, including toxicology, pathology, and safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics. In-vitro methods for conventional and quick quality control testing of sterile and non-sterile medicines and consumer products are provided by the manufacturing section. It operates in more than 20 countries, along with 90 sites around the globe.
Strategy
Charles River Laboratories’ strategy is to deliver a comprehensive and integrated portfolio of drug discovery and non-clinical development products. Provide services & solutions to support clients’ discovery and early-stage drug research, process development, scale up and manufacturing efforts, and enable it to bring new and improved therapies to market faster and more cost effectively. The company focuses on maintaining strong financial performance. The company follows inorganic growth model by acquiring companies operating globally with similar product portfolio. Apart from acquisitions, Charles River collaborates with research institutes and start-ups to develop innovative products.
